Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone

NCT02030314 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT02030314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02030314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Management of Resistant Hypertension in Kidney Transplant Patients Using Chlorthalidone
Lead sponsor
Virginia Commonwealth University
Phase
Phase 4
Overall status
Withdrawn
Start date
July 31, 2013
Completion date
April 12, 2017
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

resistant hypertension in kidney transplant patients